Pro Bono Bio is the world's leading nano-lipid, healthcare technology company focused on pain, haematology and dermatology.
- Pro Bono Bio is an innovative healthcare business engaged in the development and marketing of medical devices and drug and protein management solutions
- We provide safer, more efficient healthcare solutions than traditional pharmaceuticals alone
- Success demonstrated by range of ‘in market’ and ‘market ready’ products
- Reimbursed prescription status set to drive sales
- Market disruptive products targeting large and attractive healthcare markets with multiple benefits to both health services and patients
- We are focused on pain relief, haematology and skin care with potential to extend technology into other areas